Tajikistan Triples the Production of Medicines
Read also
DUSHANBE, 02.10.2023 (NIAT Khovar) – The volume of exports of biologically active herbal supplements from Tajikistan this year increased by 63.25 million somoni compared to last year. This was stated on September 29 during the Dushanbe International Investment Forum — 2023 in the section “Investment opportunities in the healthcare sector, prospects for the development of the pharmaceutical sector and private medicine in Tajikistan.”
The volume of production of medicines and medical products produced in Tajikistan in 2022 compared to the same period the year before increased by 3 times.
The State Program for the Development of the Pharmaceutical Industry in Tajikistan for 2021-2025 is being successfully implemented to develop the pharmaceutical industry in the country.
As part of the program, 58 domestic enterprises began producing 560 types of medicines and medical products.
These enterprises provide new jobs for more than 450 specialists and workers, and up to 4,000 workers are involved in seasonal work.
Tajikistan, IMF Discuss Human Capital Development and Economic Cooperation
Industry as a Driver of Growth: What Has Changed in 35 Years of Independence?
PamirInvest-2026: 57 investment agreements worth over 6.5 billion somoni signed at international forum
Shohin Airlines to acquire four Airbus A320neo aircraft
Tajikistan Imports Goods Worth Over $5 Billion in First Half of 2026
Citizens and Entrepreneurs Conduct 3.7 Million Non-Cash Transactions via POS Terminals and E-Wallets
Plans for Non-Ferrous Metals Industrial Cluster in Sughd Discussed in Shanghai
National Bank of Tajikistan and GGGI Discuss Advancing Sustainable Finance
Tajikistan Expands Industrial Cooperation with China’s Chongqing
Tajik Delegation Participates in Silk Road E-Commerce Cooperation and Development Forum
Tajikistan’s industrial sector creates 1,160 new jobs in first half of 2026
Trade and Economic Cooperation between Sughd and Batken Regions to Expand
